Shift Bioscience

Shift Bioscience is a biotechnology company developing an AI-powered virtual cell platform to identify novel therapeutic targets for cellular rejuvenation.

Its proprietary single-cell ageing clock measures epigenetic age at high throughput, feeding machine learning models that predict gene combinations and small molecules capable of safely reversing cellular ageing.

The platform has yielded SB000, a pipeline candidate with demonstrated rejuvenation activity across multiple cell types. Near-term therapeutic development targets age-related eye disease.